CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-02 | Naydenov Jordan G Director | Purchase | +193,500 | $2.57 | $497K | 6,451,323 |
| 2020-10-23 | Colachis Arian GC and Corporate Secretary | Purchase | +10,000 | $2.50 | $25K | 80,000 |
| 2020-10-23 | Naydenov Jordan G Director | Purchase | +120,000 | $2.49 | $298K | 6,257,823 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Purchase | +250,000 | $0.57 | $141K | 1,847,302 |
Page 1 of 1 · 4 trades